AIM To describe 30-day outcomes after intrathecal baclofen (ITB) pump placement in children and identify risk factors for readmission, reoperation, and perioperative complication using the National Surgical Quality Improvement Program-Pediatric (NSQIP-P) database.
INTRODUCTION
Children undergoing intrathecal baclofen (ITB) pump therapy constitute a population with chronic healthcare needs. Best practice guidelines for ITB pump implantation are recommended. 1 The literature on pediatric ITB pump complications indicates a high incidence of postoperative wound complications, up to 20% to 30%. [2] [3] [4] ITB pump placement is typically an elective procedure and warrants continual scrutiny of surgical technique and care processes to optimize care for this at-risk population. To our knowledge, no study to date has identified patient predictors of complications, readmission, or reoperation.
Changes in pediatric healthcare policy may follow those from healthcare reform initially affecting the adult population. There has been increasing focus on 30-day readmissions as an area for healthcare delivery optimization. The Agency for Healthcare Research and Quality estimates 3.3 million adult 30-day all-cause readmissions resulted in almost $41.3 billion of hospital costs. 5 In response, the Centers for Medicare and Medicaid Services proposed the Hospital Readmissions Reduction Program through the Patient Protection and Affordable Care Act in 2013. This programme penalizes Medicare payments to hospitals with a high 30-day readmission rate for common medical conditions. 6 While this has not affected reimbursement for pediatric surgical care to date in the USA, evaluating 30-day outcomes is warranted in order to examine how this metric translates to this surgical population. We sought to use the National Surgical Quality Improvement Program-Pediatric (NSQIP-P) database to describe perioperative outcomes of ITB pump placement surgery in children and examine risk factors for 30-day readmission and reoperation. We hypothesized that the less than 30% total baclofen pump surgery-related complication rate reported in the literature would be captured in the first 30 days after surgery.
METHOD Data source
This was a multicentre retrospective case series. Data for this study were from the 2012, 2013, and 2014 public-use files of the NSQIP-P, a quality and outcomes initiative by the American College of Surgeons (ACS) and American Pediatric Surgical Association. 7 The ACS NSQIP-P programme collects over 90 data points to measure 30-day surgical outcomes in children younger than 18 years of age. Approximately 50 participating sites across the USA contribute data each year; hospitals, surgeons, and patients are deidentified. 7, 8 At each participating institution, trained surgical clinical reviewers under the ACS NSQIP-P program (who are not involved with clinical patient care) collect data on surgical cases with the associated medical records reviewed for pre-, peri-, and postoperative details up to 30 days after the index surgery. 9 Details beyond 30 days are not recorded or available in this data set.
Inclusion criteria are children up to 18 years of age undergoing ITB pump surgery. The study cohort was thus defined by surgical procedure using the Current Procedural Terminology codes 62362, 62350, and 62362, or 62351 and 62362 (Table I) . Preoperative characteristics and 30-day perioperative events are defined variables collected in the database. End points in this study were (1) reoperation within 30 days; (2) readmission within 30 days; and (3) postoperative complications in addition to reoperation and readmission. Thus, the third end point is a composite outcome, created to encompass all three end points, including any unplanned postoperative event within 30 days (NSQIP-P-defined complication, reoperation, or readmission).
This study used a deidentified data set and does not constitute human subject research; institutional review board approval was not required.
Statistical analysis
Univariate analyses included v 2 and Fisher's exact tests (for variables with subgroup case count <5) for categorical variables, whereas two-sample t-tests were applied for continuous variables. Variables with a value of p<0.2 in univariate analyses were included in a multivariate logistic regression model. A value of p<0.05 was considered statistically significant. All data analysis was carried out with Stata 13 (Stata Corp, College Station, TX, USA).
RESULTS
Between 2012 and 2014, 426 ITB pump surgeries were recorded. Three of these surgeries had recorded an operative time of 0 minutes and were excluded from analysis. Thus, 423 surgeries were included. Patient characteristics and operative factors are given in Table I . In total, 58.2% of patients were male, 41.8% of patients were female.
Median age was 12 years (interquartile range 8-15y). Altogether, 21.5% of patients were classified as underweight (defined as body mass index ≤18.49). American Society of Anesthesiologists (ASA) physical status classification was ASA class greater than or equal to 3 in 77.4% of the patient population (https://www.asahq.org/resources/clinica l-information/asa-physical-status-classification-system). For 
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instance, ASA I refers to a healthy patient, whereas ASA III characterizes a patient with severe systemic disease.
Median operative time was 70 minutes (IQR 56-97min). Average length of stay was 3.8 days (SD 7.7d). Just over half of patients (51.8%) had 2 or less inpatient hospital days, whereas 48.0% stayed 3 or more inpatient days during the hospitalization associated with their index ITB pump surgery (Table I) .
A high number of medical comorbidities are recorded in this patient population (Table I) . Of note, 45.4% of patients required nutritional support and 10.6% had preexisting tracheostomy. Comorbidities by organ system are listed. The discharge destination for 95.5% of patients was to home, whereas 4.3% were discharged to a non-home facility. It is important to note that 75 patients (17.7% of the total sample) did not have complete height and weight data points recorded and were thus missing body mass index data. The impact of body mass index is therefore not able to be quantified conclusively with this data set. Table II shows 30-day postoperative outcomes. In total, 9.5% of patients (n=40/423) experienced any NSQIP-P complication within 30 days. Twenty-five of those 40 patients had wound-and infection-related problems. Other complications included pneumonia (2.1%), urinary tract infection (1.7%), sepsis (1.7%), and unplanned postoperative intubation (1.0%). In total, 7.3% of patients (n=31/ 423) undergoing ITB surgery had unplanned readmission within 30 days of the procedure. Reasons for readmission showed that 15 of the 31 readmitted patients had woundrelated concerns for infection at admission. Unplanned reoperation occurred in 20 of 423 (4.7%) ITB pump surgery patients within 30 days of the initial surgery. Of these 20 reoperations, six were revisions of pump/catheter, nine were removals of pump/catheter, and three were washouts ( Fig. 1) .
Univariate analysis is shown in Table III . On multivariate analysis (Table IV) , female sex was associated with a decreased risk of readmission (odds ratio [OR] 0.25, 95% confidence interval [CI] 0.09-0.65; p=0.01). Patients with ASA classification greater than or equal to 3 were associated with a decreased risk of unplanned return to surgery (OR 0.26, 95% CI 0.11-0.66; p=0.04). Length of stay of 3 or more days at index ITB pump surgery hospitalization was associated with increased risk of composite 30-day perioperative event (OR 2.33, 95% CI 1.29-4.20; p=0.01) (Fig. 2) . Age, comorbidities (including tracheostomy, nutritional support, underweight status), ethnicity, and operative time did not significantly influence rate of readmission, reoperation, complications, or composite 30-day perioperative events on multivariate analysis.
DISCUSSION
Using the ACS's NSQIP-P data to describe 30-day outcomes of ITB pump placement surgery in 423 patients, we found the readmission rate within 30 days was 7.3%, whereas unplanned return to the operating room occurred in 4.7% within 30 days of the index ITB pump surgery.
The causes of readmission were multifactorial. The most common reported reason for unplanned readmission (15/ 31 patients) within 30 days was wound-related. This national experience is similar to prior reports, such as that by Ghosh et al. 4 In their 15-year experience involving 111 patients, mechanical complications requiring pump and/or catheter revision occurred in 19.3% and infections in 21.8%. 4 In 200 consecutive cases, main complications were cerebrospinal fluid (CSF) leak, infection, and malfunction; these affected 31% of patients. 10 Complication rates decreased over time in that study, suggesting improvement with a learning curve. Complications were also decreased after the practice of subfascial pump placement was adopted. 10 In this study, we found that female patients had lower risk of readmission based on multivariate analysis. This discrepancy in readmission rates based on patient sex does not have a clear scientific explanation. We hesitate to postulate reasons for sex differences in outcomes based on anecdotal social or behavioural observations, although such non-clinical factors may play a role. This unexpected finding may serve to motivate future clinical quality-improvement initiatives aimed at developing best-practice processes modelled on patients with excellent outcomes; qualitative and quantitative data will be important to collect in such endeavours.
Albright et al. 1 reported a high incidence of occult hydrocephalus in the pediatric population considered for baclofen pumps. This disturbance in CSF dynamics is known to contribute to wound-related problems, predisposing to CSF leak. This is not well delineated in non-specialty specific NSQIP-P data collection and is likely categorized as a wound problem. This observation represents an opportunity to improve data collection in the future. Before ITB therapy, it was prudent to work up and address hydrocephalus to minimize CSF-related complications with an ITB pump. In addition, tunnelling of an intrathecal catheter through a previous spinal fusion mass without laminectomy may predispose to CSF leaks, whereas laminectomy for catheter placement may mitigate this risk. 1 Surgical technique and patient anatomy are not recorded in NSQIP-P.
Unplanned reoperation within 30 days occurred in 4.7% of cases (n=20/423). Most of these reoperations were infection-related or hardware-related, as nine were removals of pump/catheter, three were washouts, and six were revisions of pump/catheter. On multivariate analysis, we found that patients with higher ASA grade, representing those with more systemic disease, were less likely to experience unplanned return to the operating room. While it seems counterintuitive that patients in poor systemic condition would have a 'better' outcome with a lower early reoperation rate than their healthier counterparts, this finding may conceivably reflect treating physicians' higher clinical threshold to subject these patients to repeat anaesthesia. Clinical decision-making details are not available in recorded NSQIP-P data.
In terms of the composite outcome of any 30-day NSQIP-P-defined postoperative occurrence (perioperative complication, reoperation, readmission), we found that length of index surgical hospitalization stay of 3 or more days (vs <3d) was associated with a more than twofold higher risk of experiencing a 30-day postoperative event. While the mechanism of this association is likely multifactorial, it stands to reason that those with a longer inpatient postoperative course after surgery may have underlying comorbidities or other issues associated with their wound, health, or ability of the family to care for the child at home. We attempted to use operative time as a proxy for difficulty of surgery, although this cannot be completely inferred or known; there was no significant association with length of surgery and postoperative complication.
Another important finding related to this patient cohort lies in the descriptive statistics: there is a significant number of comorbidities in the population, as reflected by the high proportion with ASA greater than or equal to 3 (77.5%). Almost half of the population (45.4%) required nutritional support preoperatively. Data on height and weight for age were incomplete for 17.7% of the cohort, limiting ability for interpretation of impact of body mass index on outcomes. Although our multivariate regression analysis did not find a significant relationship between comorbidities of existing tracheotomy, nutritional support, and perioperative complications, these pre-existing medical problems represent perioperative risk, as well as opportunities for preoperative medical optimization. This suggestion supports our current institutional philosophy. We have implemented a multidisciplinary program involving specialists from the nutrition and dietician service, developmental pediatrics, and physical medicine and rehabilitation departments to optimize patients before this elective surgery. Given that surgical-site infection issues make up almost half of those readmitted to the hospital, any means to reduce this burden should be explored.
With the known 30-day occurrences, this information potentially allows us to target areas of opportunity for process improvement, ranging from perioperative patient selection, medical optimization before and after surgery, and postoperative care coordination. A note of caution is that delayed manifestation of surgical sequelae is not captured when limiting data collection to the 30-day perioperative period. Indeed, given the long-term hardware implantation for these surgeries, it is likely patients are returning with wound complications, therapy-related issues, or device problems beyond the 30-day window. Mechanical complications involving the pump or catheter are reported to be a significant portion of readmission/revisions with longer follow-up. 4 Catheter-related complications are reported in 5% to 12% of patients between 24 and 108 months after implantation. Our group found more than 20% of patients had an infection or implant-related complication at 6-month follow-up in a national cohort treated at children's hospitals. 11 In addition, infection risk is suggested to increase in a linear fashion, with no observable plateau in annual rate of infection until approximately 8 years postoperatively. 10 These findings underlie the importance of long-term data collection to appropriately evaluate the delayed surgical complications associated with implantable devices. Thus, our hypothesis was supported, i.e. that less than half of total expected complications in this surgical population are found in the 30-day time period reported in NSQIP-P. However, given that long-term data are not available in this data set, long-term outcomes for this particular study cohort are not known. Total expected complications in this context are inferred based on the literature.
Additional limitations of this study include those inherent to the NSQIP-P data set. The variables collected are predetermined. Operative indications and specific surgical technique are not known. For instance, clinically relevant information about features of spasticity and dystonia are difficult to characterize based on coding. Anatomical considerations and imaging characteristics are not available. We are unable to discern severity of complications or quantify the amount of reported symptoms such as postoperative headache or pain. There are missing data points. This gap in the data serves as an area for improvement for the NSQIP-P data collection programme as a whole. Another statistical limitation may stem from a low incidence of a subset of potential postoperative diagnoses. Formally, a larger sample size is needed for accurate estimation. Importantly, we are not able to assess if readmissions were preventable. Some perioperative problems may sometimes be unavoidable, even with the very best care. Finally, this study is subject to the inherent biases of retrospective review. The ACS NSQIP-P program sampling method dictates that the year is divided into 46 eight-day collection cycles; only a quota of cases meeting inclusion criteria of selected Common Procedural Terminology codes are captured. 12 This method does not capture all cases and may not fully reflect the impact of surgical centre volume.
Hospitals and administrative bodies have recently focused attention on methodologies to quantify and improve quality measures in patient outcomes across all surgical specialties. Based on this study, we have identified several common causes of 30-day readmission. Patients requiring additional procedures or pharmacotherapy may be the focus of future investigations to help guide measures that will potentially prevent 30-day readmissions, such as preoperative work-up, surgical technique, and coordinated discharge planning. Interventions may encompass preoperative evaluation pathways, early postdischarge communication and follow-up, and standardized protocols to ensure adequate evaluation and planning before patients are discharged from the hospital. This may also include appropriate specialized home care after discharge. Preventative measures focused on surgical site infections are relevant to all surgical specialties. 13, 14 The burden of readmission is considerable (7.3%). Preventing adverse outcomes and optimizing health resource utilization remain opportunities for surgeons to reach out to multidisciplinary teams to create workflows that ensure better patient outcomes and quality in care.
The results of this study should be interpreted cautiously and with the understanding of the inherent limitations of the data source. A goal of the ACS NSQIP-P program is to provide hospitals with an observed-to-expected ratio of complications to help guide areas for improvement and establish national benchmarking. 12 Short follow-up limited to 30 days is intended to put the focus on quality metrics surrounding perioperative events; while this may be appropriate for general surgery, 15 this is clearly not adequate for neurosurgery. In practice, 30-day follow-up provides a narrow focus lacking many factors and outcomes of clinical relevance specific to pediatric neurosurgery. Future directions would ideally bridge this gap to achieve comprehensive measures and accumulate data to generate best-practice guidelines for all phases of care, including long-term outcomes.
Data from this study of the NSQIP-P provide insights and national benchmarks for ITB pump placement in the pediatric population. Over 7% of patients required readmission within 30 days and almost 5% undergo reoperation within 30 days. There are significant medical comorbidities in this cohort. These results highlight opportunities for quality improvement in clinical practice and examine the methodology of database collection.
